Two-year Ocular and Developmental Outcomes of a Phase 1 Dosing Study of Bevacizumab for Retinopathy of Prematurity
Journal of American Association for Pediatric Ophthalmology and Strabismus(2022)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined